Although the dependency on BCL-xL is often caused by alterations in the expression of other BCL-2 family proteins, such as MCL-1 and NOXA [24,47,48], the combination of everolimus and gemcitabine in malignant meningioma cells did not consistently alter the expression of these proteins in the present study. Here, BCL2L1 is linked to meningioma.